Skip to Content

Cancer Related Fatigue in Brain Cancer Patients

A Phase III/Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil) to Reduce Cancer-Related Fatigue in Patients with Globastoma Multiforme.

Objective

To determine if the addition of Armodafinil will help reduce patient's reported fatigue associated with chemotherapy and radiation therapy.

Inclusion Criteria:
Must have completed radiation therapy treatments greater than 21 days and less than or equal to 24 months before enrollment. Must meet a certain level of fagitue. Must be willing to complete questionnaires.

Exclusion Criteria:
Currently not taking any medication of ADHD, severe anxiety disorder, schizophrenia or substance abuse.

IRB Protocol Number
A221101

Clinical Trial Categories

  • Brain Cancer
Contact
Margaret White, RN OCN, CC at 603-232-8908

Location

  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6000